FDA Urges Compounding Firms to ‘Know Their API Supplier’

The FDA called on drug compounders to know their active pharmaceutical ingredient (API) suppliers as it issued a warning letter to Houston, Texas-based Professional Compounding Centers of America (PCCA) for using a supplier whose drug ingredients had been placed on an import alert.
Source: Drug GMP Report